Natural history and progression of metabolic dysfunction-associated steatotic liver disease
Most Cited Paper
in Liver Disease Diagnosis and Treatment
18 Months Post-Publication
Class of 2026
“Natural history and progression of metabolic dysfunction-associated steatotic liver disease”
A research intelligence initiative by Pepkio
pri.pepkio.com
Topics
Metabolic dysfunction-associated steatotic liver disease · Metabolic dysfunction-associated steatotic liver disease · natural history · Disease progression · Hepatic steatosis · Fibrosis progression · Cirrhosis · Hepatocellular carcinoma · Risk factors · insulin resistance · obesity · type 2 diabetes · cardiovascular outcomes · Liver-related mortality · Biomarkers · longitudinal cohort studies · progression rates · Steatohepatitis · Steatohepatitis · liver biopsy
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Liver Disease Diagnosis and Treatment Papers, Class of 2026. https://pri.pepkio.com/top-papers/liver-disease-diagnosis-and-treatment/2026. Accessed 2026-07-24. Methodology Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459